Source: International Congress 2014 – Latest insights in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Manson, A. James, J. Säfholm, S. E. Dahlén, M. Adner (Stockholm, Sweden). LATE-BREAKING ABSTRACT: The bitter tastants chloroquine and noscapine relax human bronchial smooth muscle by different effects on intracellular calcium signalling. Eur Respir J 2014; 44: Suppl. 58, 2821

Member's Comments

No comment yet.

Related content which might interest you: Bitter taste receptors are expressed and induce relaxation of human bronchi Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta2-adrenoceptor agonists in airway smooth muscle Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Beneficial effects of menthol are mediated via a TRPM8-independent mechanism Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 LATE-BREAKING ABSTRACT: The PDE4 inhibitor CHF-6001 and LAMAs cooperatively inhibit bronchoconstriction-induced remodeling in lung slices Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Endothelin-1-mediated contraction of mouse small airways is resistant to salbutamol, but sensitive to rosiglitazone Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Synergistic effects by combination of tiotropium with olodaterol result from cross talk between muscarinic and β2-adrenergic receptors via allosteric modulation Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Slow dissociation kinetics of LAMAs contribute to the functional interactions with LABAs Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Activation of TRPV4 causes bronchoconstriction: A possible role in respiratory disease? Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Allergen exposed primary human bronchial epithelial cells have inhibited transport of salbutamol sulphate only when functional organic cation tranporters are present Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Bronchodilator activity of the combination of salbutamol hemisuccinate and methatropium iodide compared with monotherapy in preclinical studies Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 LATE-BREAKING ABSTRACT: Corticosteroid responsiveness in COPD Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016 Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 Pharmacological interaction between glycopyrronium bromide and indacaterol fumarate on the human airways tone Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM) Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Abediterol has higher bronchodilatory potency than other long-acting beta2-receptor agonists in a guinea pig model Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 IL33 and TNFalpha synergistically enhance store operated Ca2+ entry in cultured human airway smooth muscle cells Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013